---
layout: post
title: "港A两地CXO板块连续第二日反弹 估值底部显现+利好不断"
date: 2022-02-15 10:35:19 +0800
categories: emnews
tags: 东财滚动新闻
---
> 延续昨日反弹态势，CXO板块今日盘中继续上涨。A股诚达药业20cm涨停，博腾股份涨超10%，昭衍新药涨停，美迪西、凯莱英涨超8%，药明康德和康龙化成涨超7%，泰格医药涨超3%；港股金斯瑞和药明康德涨超9%，昭衍新药涨超8%，药明生物、方达控股涨超7%，泰格医药、康龙化成涨超6%。

<!-- EM_StockImg_Start --><p style="text-align:center;"><a href="http://quote.eastmoney.com/unify/r/116.02359" data-code="02359|116|5" data-code2="02359|116|3|" class="EmImageRemark" target="_blank"><img src="https://webquoteklinepic.eastmoney.com/GetPic.aspx?nid=116.02359&imageType=k&token=28dfeb41d35cc81d84b4664d7c23c49f&at=1" border="0" alt="K图 02359_0" data-code="K 02359|116|5" data-code2="K 02359|116|3|" style="border:#d1d1d1 1px solid;" width="578" height="276" /></a></p><!-- EM_StockImg_End --><p style="display:none;height:1px;overflow:hidden;"><br /></p><!-- EM_StockImg_Start --><p style="text-align:center;"><a href="http://quote.eastmoney.com/unify/r/116.01548" data-code="01548|116|5" data-code2="01548|116|3|" class="EmImageRemark" target="_blank"><img src="https://webquoteklinepic.eastmoney.com/GetPic.aspx?nid=116.01548&imageType=k&token=28dfeb41d35cc81d84b4664d7c23c49f&at=1" border="0" alt="K图 01548_0" data-code="K 01548|116|5" data-code2="K 01548|116|3|" style="border:#d1d1d1 1px solid;" width="578" height="276" /></a></p><!-- EM_StockImg_End --><p>延续昨日反弹态势，CXO板块今日盘中继续上涨。A股<span id="stock_0.301201"><a href="http://quote.eastmoney.com/unify/r/0.301201" class="keytip" data-code="0,301201">诚达药业</a></span><span id="quote_0.301201"></span>20cm涨停，<span id="stock_0.300363"><a href="http://quote.eastmoney.com/unify/r/0.300363" class="keytip" data-code="0,300363">博腾股份</a></span><span id="quote_0.300363"></span>涨超10%，<span id="Info.116.06127"><a href="http://quote.eastmoney.com/unify/r/116.06127" class="keytip" data-code="116,06127">昭衍新药</a></span>涨停，<span id="stock_1.688202"><a href="http://quote.eastmoney.com/unify/r/1.688202" class="keytip" data-code="1,688202">美迪西</a></span><span id="quote_1.688202"></span>、<span id="Info.116.06821"><a href="http://quote.eastmoney.com/unify/r/116.06821" class="keytip" data-code="116,06821">凯莱英</a></span>涨超8%，<span id="Info.116.02359"><a href="http://quote.eastmoney.com/unify/r/116.02359" class="keytip" data-code="116,02359">药明康德</a></span>和<span id="Info.116.03759"><a href="http://quote.eastmoney.com/unify/r/116.03759" class="keytip" data-code="116,03759">康龙化成</a></span>涨超7%，<span id="Info.116.03347"><a href="http://quote.eastmoney.com/unify/r/116.03347" class="keytip" data-code="116,03347">泰格医药</a></span>涨超3%；港股金斯瑞和<span web="1" href="http://quote.eastmoney.com/unify/r/116.02359" class="em_stock_key_common" data-code="116,02359">药明康德</span>涨超9%，<span web="1" href="http://quote.eastmoney.com/unify/r/116.06127" class="em_stock_key_common" data-code="116,06127">昭衍新药</span>涨超8%，<span id="Info.116.02269"><a href="http://quote.eastmoney.com/unify/r/116.02269" class="keytip" data-code="116,02269">药明生物</a></span>、<span id="Info.116.01521"><a href="http://quote.eastmoney.com/unify/r/116.01521" class="keytip" data-code="116,01521">方达控股</a></span>涨超7%，<span web="1" href="http://quote.eastmoney.com/unify/r/116.03347" class="em_stock_key_common" data-code="116,03347">泰格医药</span>、<span web="1" href="http://quote.eastmoney.com/unify/r/116.03759" class="em_stock_key_common" data-code="116,03759">康龙化成</span>涨超6%。<br /></p><p>CXO板块近日迎来多重利好。2月11日，<span web="1" href="http://quote.eastmoney.com/unify/r/0.300363" class="em_stock_key_common" data-code="0,300363">博腾股份</span><span id="Info.3332"><a href="http://data.eastmoney.com/notices/" class="infokey">公告</a></span>与<span id="stock_106.PFE"><a href="http://quote.eastmoney.com/unify/r/106.PFE" class="keytip" data-code="106,PFE">辉瑞</a></span><span id="quote_106.PFE"></span>新签订6.81亿美金订单，根据订单体量机构预计可能为<span web="1" href="http://quote.eastmoney.com/unify/r/106.PFE" class="em_stock_key_common" data-code="106,PFE">辉瑞</span>新冠治疗药物相关CDMO订单。2月12日CDE官网公布附条件批准<span web="1" href="http://quote.eastmoney.com/unify/r/106.PFE" class="em_stock_key_common" data-code="106,PFE">辉瑞</span>公司新冠病毒治疗药物奈玛特韦片/利托那韦片组合包装(即Paxlovid)进口注册。进行新冠治疗药物及CDMO供应链持续迎来重磅利好。另外，2月13日<span web="1" href="http://quote.eastmoney.com/unify/r/116.03347" class="em_stock_key_common" data-code="116,03347">泰格医药</span>公告将以不高于120.00元/股<span id="Info.3285"><a href="http://data.eastmoney.com/gphg/" class="infokey">回购</a></span>2.5亿-5亿公司股票，用于后期实施A股股权激励计划或A股员工持股计划。</p><p><span id="stock_1.601878"><a href="http://quote.eastmoney.com/unify/r/1.601878" class="keytip" data-code="1,601878">浙商证券</a></span><span id="quote_1.601878"></span>认为，CXO板块在此前的持续下跌后，估值底部逐步显现，目前CXO板块普遍处于历史估值底部，在外部利好催化不断，内部经营质量和海外大客户认可度持续提升前景下，看好CXO行情。</p><p class="em_media">（文章来源：格隆汇）</p>

<http://hk.eastmoney.com/news/1535,202202152276770584.html>

[返回东财滚动新闻](//finews.withounder.com/emnews/)｜[返回首页](//finews.withounder.com/)